AMCO United Holding Limited announced that on 8 September 2026 it sold its entire holding of 24.56 million shares in BFB Health Limited to BFB Group Limited for HK$10.56 million in cash, excluding transaction costs. The average selling price was HK$0.43 per share. Following the transaction, AMCO United no longer owns any BFB Health shares.

Financial impact • Gross proceeds: HK$10.56 million (≈US$1.35 million). • Estimated pre-audit gain: HK$6.40 million, calculated as the difference between proceeds and original investment cost. • Proceeds allocation: general working capital, inventory procurement to enhance the Group’s medical product mix, and prospective investments; full deployment targeted by 31 December 2026.

Strategic rationale Management cited three drivers for the disposal: 1. Recent share-price performance and liquidity of BFB Health. 2. Heightened market volatility and macroeconomic uncertainties. 3. Desire to rebalance the securities portfolio, improve cash reserves and support expansion of the Group’s core medical business.

Regulatory classification The deal’s size exceeded 5 % but was below 25 % of the Group’s asset and revenue thresholds, making it a “discloseable transaction” under Chapter 14 of Hong Kong’s Listing Rules and requiring public disclosure.

Counterparties • Purchaser: BFB Group Limited, an investment holding company ultimately beneficially owned by Wu Mansheng; classified as an Independent Third Party. • Target: BFB Health Limited (HKEX: 205), which reported 2025 revenue of HK$33.12 million and a net loss of HK$19.99 million, with total assets of HK$401.25 million.

Company overview AMCO United is an investment holding company engaged in the sale of medical and plastic-moulding products, provision of money-lending services, and securities investment. The board affirmed that the disposal terms are fair, on normal commercial terms, and in the best interests of shareholders.